Understanding rare infections post-lung transplantation

Expert Rev Respir Med. 2021 Mar;15(3):325-338. doi: 10.1080/17476348.2021.1843428. Epub 2020 Nov 18.

Abstract

Introduction: Lung transplant recipients are at the highest risk of infectious complications among all solid-organ transplant (SOT) recipients. In the current era, many standardized protocols in terms of diagnostic algorithms, prophylaxis, and therapeutic strategies have improved the management of the most common infectious complications. Conversely, diagnosis of rare infections can be particularly challenging and this can delay appropriate treatment.Areas covered: This article will review the epidemiology, clinical presentation, diagnostic and therapeutic management of certain rarely reported viral, fungal, bacterial and parasitic infections in lung transplant recipients.Expert opinion: Once the most frequent infections are excluded, clinical suspicion combined with molecular diagnostic methods such as targeted and broad-spectrum PCRs can allow diagnosis of a rare infection. A multidisciplinary team, including transplant pulmonologists, transplant infectious diseases specialists, microbiologists and pathologists is essential for prompt diagnosis and optimal therapeutic management.

Keywords: HHV-8; hev; idiopathic hyperammonemia syndrome; nocardiosis; parasitic infection; polyomavirus; rare fungal infections; rhodococus hoagii.

MeSH terms

  • Humans
  • Lung Transplantation* / adverse effects
  • Organ Transplantation*
  • Transplant Recipients